Alexandra G Lopez-Aguiar

Dr. Alexandra G Lopez-Aguiar

The Ohio State University Wexner Medical Center, Columbus, Georgia, USA
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 March 2022 in Cancers
Verified
Journal Article
Open access
PDF file
Lucia CasadeiLucia Casadei
Lucia Casadei
FFFernanda Costas Casal de Faria
Fernanda Costas Casal de Faria
ALAlexandra G Lopez-Aguiar
Alexandra G Lopez-Aguiar
RPRaphael E. E Pollock
Raphael E. E Pollock
VGValerie Grignol
Valerie Grignol
Liposarcoma (LPS) is the most prevalent soft tissue sarcoma histological subtype. When it occurs in the abdomen the overall survival rate is as low as 10% at 10 years and is fraught with high rates of recurrence, particularly for the more aggressive dedifferentiated subtype. Surgery remains the mainstay of treatment. Systemic therapies for the treatment of metastatic or unresectable disease have low response rates. Deep understanding of well-differentiated and de-differentiated LPS (WDLPS and DDLPS, respectively) oncologic drivers is necessary for the development of new efficacious targeted therapies for the management of this disease. This review discusses the current treatments under evaluation for retroperitoneal DDLPS and the potential targetable pathways in DDLPS.